| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 209,6 k € | -5.5% | 221,8 k € | +37.9% | 160,9 k € | -20.2% | 201,6 k € | +40.8% | 143,1 k € | +2.7% | 139,4 k € | +15.6% | 120,5 k € | -10.9% | 135,2 k € | +23.5% | 109,5 k € | -11.0% | 123,0 k € | +5.5% | 116,7 k € | +183.2% | 41,2 k € | -54.2% | 90,0 k € | -10.4% | 100,4 k € | -2.4% | 103,0 k € | -3.8% | 107,0 k € | -1.7% | 108,9 k € | +26.8% | 85,9 k € | -3.9% | 89,3 k € | |
| EBITDA | 199,2 k € | +4.2% | 191,1 k € | +48.0% | 129,1 k € | -24.7% | 171,4 k € | +44.6% | 118,6 k € | +6.2% | 111,7 k € | +20.8% | 92,4 k € | -15.8% | 109,8 k € | +29.5% | 84,8 k € | -13.2% | 97,7 k € | +5.6% | 92,5 k € | +498.4% | 15,5 k € | -76.7% | 66,3 k € | -12.6% | 75,9 k € | +2.1% | 74,3 k € | -18.7% | 91,4 k € | -6.3% | 97,5 k € | +30.0% | 75,0 k € | -5.8% | 79,6 k € | |
| Operating profit | 179,0 k € | +4.9% | 170,7 k € | +55.3% | 109,9 k € | -32.2% | 162,0 k € | +48.2% | 109,3 k € | +17.1% | 93,4 k € | +40.7% | 66,4 k € | -24.3% | 87,8 k € | +38.4% | 63,4 k € | -15.3% | 74,9 k € | +9.8% | 68,2 k € | +613.7% | -13,3 k € | -138.1% | 34,8 k € | -22.8% | 45,1 k € | +94.6% | 23,2 k € | -42.2% | 40,1 k € | -14.7% | 47,0 k € | +135.4% | 20,0 k € | -16.3% | 23,9 k € | |
| Profit/loss | 135,1 k € | +6.4% | 126,9 k € | +47.1% | 86,3 k € | -28.7% | 121,0 k € | +33.7% | 90,5 k € | +21.1% | 74,7 k € | +42.3% | 52,5 k € | -10.4% | 58,6 k € | +37.3% | 42,7 k € | +10.9% | 38,5 k € | -2.4% | 39,4 k € | +450.3% | 7,2 k € | -39.6% | 11,9 k € | -52.6% | 25,0 k € | +1205.4% | 1,9 k € | -86.1% | 13,8 k € | -69.2% | 44,8 k € | +1330.6% | 3,1 k € | -81.5% | 16,9 k € | |
| Equity | 684,3 k € | +24.6% | 549,3 k € | +30.1% | 422,3 k € | +25.7% | 336,1 k € | +22.8% | 273,7 k € | +23.5% | 221,7 k € | -9.5% | 244,8 k € | +4.9% | 233,4 k € | +33.5% | 174,8 k € | +32.3% | 132,1 k € | +41.1% | 93,6 k € | -18.0% | 114,2 k € | +6.7% | 107,1 k € | +12.5% | 95,2 k € | -0.0% | 95,2 k € | +2.1% | 93,3 k € | -40.2% | 156,0 k € | +40.3% | 111,2 k € | +1.4% | 109,6 k € | |
| Total assets | 728,1 k € | +16.6% | 624,5 k € | +18.8% | 525,7 k € | +21.8% | 431,5 k € | +44.2% | 299,3 k € | +14.4% | 261,7 k € | -8.6% | 286,3 k € | -2.3% | 292,9 k € | +31.5% | 222,7 k € | +13.5% | 196,2 k € | +10.8% | 177,1 k € | -11.5% | 200,0 k € | -4.1% | 208,5 k € | -6.5% | 222,9 k € | -11.4% | 251,6 k € | -12.1% | 286,1 k € | -26.5% | 389,2 k € | +7.4% | 362,3 k € | -7.4% | 391,1 k € | |
| Cash | 167,7 k € | +44.8% | 115,8 k € | -41.6% | 198,4 k € | +260.1% | 55,1 k € | +52.3% | 36,2 k € | -2.0% | 36,9 k € | +96.4% | 18,8 k € | -20.0% | 23,5 k € | +352.0% | 5,2 k € | -75.7% | 21,3 k € | +133.1% | 9,2 k € | -41.1% | 15,5 k € | +281.3% | 4,1 k € | -43.4% | 7,2 k € | -24.0% | 9,5 k € | +23.5% | 7,7 k € | -75.9% | 31,8 k € | +13.7% | 28,0 k € | -4.1% | 29,2 k € | |
| Debts | 43,6 k € | -40.1% | 72,8 k € | -29.1% | 102,7 k € | +9.9% | 93,4 k € | +273.0% | 25,0 k € | -37.4% | 40,0 k € | -3.5% | 41,4 k € | -30.1% | 59,3 k € | +24.0% | 47,8 k € | -24.9% | 63,7 k € | -23.7% | 83,4 k € | -2.8% | 85,8 k € | -15.4% | 101,5 k € | -20.6% | 127,7 k € | -18.3% | 156,4 k € | -18.9% | 192,8 k € | -17.3% | 233,2 k € | -7.1% | 251,1 k € | -10.8% | 281,5 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,6 | 0,6 | 0,7 | 0,3 | 0,3 | 0,3 | 0,3 | |||||||||||||||||||
Private limited company · Tessenderlo-Ham · incorporated on 27/03/2001
Private limited company profitable and well capitalised. Cash position rising (+44.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. STEFAN VANKRUNKELSVEN is a Private limited company incorporated in 2001. Its main activity is: General medical practice activities. Its registered office is in Tessenderlo-Ham.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette